---  
layout: startup_page  
title: "Avenzo Therapeutics"  
id: "avenzotx.com"  
permalink: "/avenzotherapeuticsavenzotx.com03262024/"  
website: "http://www.avenzotx.com/"  
funding_round: "Series A1"  
funding_amount: "$150M"  
investors: "New Enterprise Associates (NEA), Deep Track Capital, Sofinnova Investments, Sands Capital, INCE Capital, TF Capital, Delos Capital, Quan Capital"  
about: "Avenzo Therapeutics is a clinical-stage biotechnology company developing next-generation oncology therapeutics. Their lead drug candidate, AVZO-021, is a CDK2 inhibitor currently in a Phase 1 clinical study for treating advanced solid tumors. The company aims to advance innovative oncology therapies for patients."  
markets: "Biotechnology, Oncology"  
hq: "San Diego, California, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/avenzotx"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/avenzo-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/515541-25"  

date_display: "26-Mar-2024"  
date: "2024-03-26"

# SEO Optimization  
meta_title: "Avenzo Therapeutics - Series A1 Funding ($150M)"  
meta_description: "Avenzo Therapeutics, Avenzo Therapeutics is a clinical-stage biotechnology company developing next-generation oncology therapeutics. Their lead drug candidate, AVZO-021, i..."  
meta_keywords: "Avenzo Therapeutics, Biotechnology, Oncology, Series A1 funding"  
canonical_url: "https://startup.projectstartups.com/avenzotherapeuticsavenzotx.com03262024/"  
---